Gargallo Viola Domingo

Director · Spanish companies register · 2 companies

Companies :
2 (1 current, 1 former)
Linked companies :
FUNDITEC MEDICINES RESEARCH INSTITUTE S.L, ABAC THERAPEUTICS SL

Summary

Gargallo Viola Domingo appears in the Spanish commercial register as a director of 2 companies, 1 current and 1 former. Currently Consejero of FUNDITEC MEDICINES RESEARCH INSTITUTE S.L (Barcelona) since 11 February 2026. FUNDITEC MEDICINES RESEARCH INSTITUTE S.L is based in Esplugues de Llobregat and operates in Investigación y desarrollo experimental en biotecnología (CNAE 7211) — Sociedades de responsabilidad limitada, an active company, incorporated on 18 February 2026, share capital of €3,000. The earliest registered mandate dates from 7 August 2014, at ABAC THERAPEUTICS SL; the most recent began on 11 February 2026. The offices held are Consejero and Administrador Solidario. The companies are registered in Barcelona. The boards of these companies also include Fundacion Tecnologica Advantx, Navarro Rodriguez Antonio and Joaquin Nicolau Juan Miguel.

Offices held

ConsejeroAdministrador Solidario

Commercial registries

Barcelona

Companies · current (1)

FUNDITEC MEDICINES RESEARCH INSTITUTE S.LCurrent

Consejero since 11/02/2026

Active · Investigación y desarrollo experimental en biotecnología (CNAE 7211) · Esplugues de Llobregat · Sociedades de responsabilidad limitada · incorporated 18/02/2026 · capital €3,000 · 2 BORME filings

Corporate purpose: LA INVESTIGACION, DESARROLLO E INNOVACION EN MEDICINAS Y PRODUCTOS FARMACEUTICOS, CON ESPECIAL FOCO EN ENFERMEDADES INFECCIOSAS Y RESISTENCIA ANTIMICROBIANA; EL DESCUBRIMIENTO, OPTIMIZACION Y DESARROLLO, ETC.

B26629196 · Barcelona

Companies · former (1)

ABAC THERAPEUTICS SLFormer

Former Administrador Solidario · from 07/08/2014 to 22/10/2019

Active · Fabricación de especialidades farmacéuticas (CNAE 2120) · Esplugues de Llobregat · Sociedad Limitada (SL) · incorporated 08/07/2014 · capital €259,407 · 25 BORME filings

Corporate purpose: DESCUBRIR Y DESARROLLAR NUEVOS FARMACOS ANTIBACTERIANOS.CNAE:2120.

B66339417 · Barcelona

Timeline (10)

  1. 11/02/2026Appointed Consejero of FUNDITEC MEDICINES RESEARCH INSTITUTE S.L · Barcelona
  2. 22/10/2019Ceased as Administrador Solidario of ABAC THERAPEUTICS SL · Barcelona
  3. 21/06/2019Appointed Administrador Solidario of ABAC THERAPEUTICS SL · Barcelona
  4. 15/06/2018Ceased as Apoderado Solidario/Mancomunado of ABAC THERAPEUTICS SL · Barcelona
  5. 15/06/2018Appointed Apoderado Solidario of ABAC THERAPEUTICS SL · Barcelona
  6. 22/02/2018Ceased as Consejero of ABAC THERAPEUTICS SL · Barcelona
  7. 19/02/2016Appointed Apoderado Solidario/Mancomunado of ABAC THERAPEUTICS SL · Barcelona
  8. 05/01/2016Ceased as Administrador Conjunto of ABAC THERAPEUTICS SL · Barcelona
  9. 05/01/2016Appointed Consejero of ABAC THERAPEUTICS SL · Barcelona
  10. 07/08/2014Appointed Administrador Conjunto of ABAC THERAPEUTICS SL · Barcelona

Co-directors (3)

FUNDITEC MEDICINES RESEARCH INSTITUTE S.L

Network map

5 nodes Person Company
gargallo-viola-domingoFUNDITEC MEDICINES RESEARCH INSTITUTE S.LFUNDITEC MEDICINES R…FUNDACION TECNOLOGICA ADVANTXFUNDACION TECNOLOGIC…NAVARRO RODRIGUEZ ANTONIONAVARRO RODRIGUEZ AN…JOAQUIN NICOLAU JUAN MIGUELJOAQUIN NICOLAU JUAN…

Identity matched by name · homonyms possible.